CDK1 and lung adenocarcinoma: In fact, combination of inhibition of CDK1 and PARP in BRCA-proficient cells resulted in reduced colony formation, tumor xenograft growth inhibition and tumor regression with prolonged survival in a mouse lung adenocarcinoma model, despite BRCA1 downregulation48.